Updated just now · Live
Eli Lilly and Company discovers, develops, and markets pharmaceutical products worldwide. The company focuses on diabetes, oncology, immunology, and neuroscience, with leading products including Mounjaro, Verzenio, and Trulicity.
Eli Lilly and Company operates in the Healthcare sector and is a constituent of the S&P 500 index. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for LLY.
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). LLY Stock Intelligence Report. [stoxpulse.com/stocks/lly]
Disclaimer: The information on this page about Eli Lilly and Company (LLY) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Eli Lilly and Company.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
Earnings beat by 27%
Mar 31
Sulzberger bought 4.39 shares
Jun 15
LUCIANO bought 14.094 shares
Jun 15
Pharma heavyweights clash over anti-obesity drug a...
2h ago
Novo Nordisk Lawsuit Against Eli Lilly: Wegovy Mak...
2h ago
StoxPulse AI results for LLY: Pulse Score 49/100. Primary sentiment trends from 15 news sources and 20 SEC filings indicate a neutral outlook.
Market Cap
$1.08T
P/E Ratio
46.8
EPS
$7.39
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Jun 25
+14.5%
Sep 25
+22.0%
Dec 25
+11.9%
Mar 26
+27.0%
Beat estimates 4 of 4 quarters (100%)
Eli Lilly and Company discovers, develops, and markets pharmaceutical products worldwide. The company focuses on diabetes, oncology, immunology, and neuroscience, with leading products including Mounjaro, Verzenio, and Trulicity.
Pharma heavyweights clash over anti-obesity drug ads
Novo Nordisk Lawsuit Against Eli Lilly: Wegovy Maker Alleges Misleading Zepbound, Mounjaro Ads
Novo Nordisk sues Eli Lilly in high-stakes GLP-1 advertising feud
Wegovy maker sues rival Eli Lilly over 'deliberately false' GLP-1 ads
Novo Nordisk Files Deceptive Advertising Lawsuit Against Rival Eli Lilly
Novo Nordisk sues Eli Lilly over misleading weight loss drug ads
Novo Nordisk Sues Eli Lilly Over Zepbound and Mounjaro Ads
Novo Nordisk accuses Eli Lilly of deceptive marketing in weight-loss fight